Anyuan Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese private company located in Shanghai. The firm develops biological macromolecular drugs. It was founded in 2016. Qiang Li is currently the CEO of the company.

Bioway, Inc. engages in the research and development of medicine. The company was founded by Kim Jong-Woo on March 4, 2015 and is headquartered in Seoul, South Korea.

Nantong Yichen Biomedical Technology Co., Ltd., established on 2021-02-24, Business scope includes licensed projects:Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Biochemical product technology research and development;Fermentation process optimization technology research and development;Engineering and Technology Research and Experimental Development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Shanghai Yichen Pharmaceutical Technology Co., Ltd., established on 2015-07-07, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Medical Technology(genetically modified organism,Except human stem cell genetic diagnosis)Technology development in the technical field,technical consulting,Technical Services,technology transfer,laboratory reagent,Laboratory equipment and consumables,R & D and sales of instruments and meters,Research and development of pharmaceutical intermediates,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)Sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Toshiba Corporation (株式会社東芝 Kabushiki-gaisha Tōshiba, English: /təˈʃiːbə, tɒ-, toʊ-/) is a Japanese multinational conglomerate headquartered in Tokyo, Japan. Its diversified products and services include information technology and communications equipment and systems, electronic components and materials, power systems, industrial and social infrastructure systems, consumer electronics, home appliances, medical equipment, office equipment, as well as lighting and logistics.

Korea Ginseng Corp. manufactures and supplies herbs. The firm offers ginseng based food products and beverages such as ginseng tea, capsules, and other related drinks. It has operations in China, Taiwan, Japan, and the United States. The company was founded on January 1, 1999 and is headquartered in Daejeon, Korea.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Yunnan Shunxi Regenerative Medicine Engineering Co., Ltd., established on 2015-04-30, Business scope includes stem cell storage technology services;stem cell collection,detection,to prepare,Freezing and Serving;Research and Development of Stem Cell Biotechnology,technology transfer,technical consulting,Technical Services;Research and development of immune cell technology,technology transfer,technical consulting,Technical Services;Research and development of medical testing technology,technology transfer,technical consulting,Technical Services;health check;Health Information Consulting Service;Research and Development of Bioelectronic Technology,technology transfer,Technical Services;Research and development of cosmetics-related technologies,cosmetic,In vitro diagnostic reagents,Sales of Medical Devices;Genetic data analysis service;Organize cultural and artistic exchange activities;Undertake conferences and commodity exhibitions(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Tianbang Bio Technology Co., Ltd., part of Beijing Dabeinong Technology Group Co., Ltd., is a Chinese company located in Nanjing. The firm engages in researching and developing animal bio products. On March 12, 2014 Beijing Dabeinong Technology Group Co., Ltd. acquired Nanjing Tianbang Bio Technology Co., Ltd. for $1.94 million.

Chongqing Paijin Biotechnology Co., Ltd., established on 2013-03-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Biochemical product technology research and development,Fermentation process optimization technology research and development,Engineering and Technology Research and Experimental Development,Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Huaren Pharmaceutical Co., Ltd. engages in development, manufacture, and sale of non polyvinyl chloride and non-PVC large capacity preparations. Its products include basic, therapeutic, cosmetics, sanitary, disposable medical products and nutritional infusion categories. The company was founded on May 20, 1998 and is headquartered in Qingdao, China.

Coletica SA, develops performance-based skin care compounds and related technologies for the cosmetic and personal care industries. Coletica has held a major presence in the active ingredients business for skin care, specializing in vectorization (micro, nano-encapsulation, molecular association, etc.) and has partnered in many major innovations as the worldwide leader in reconstructed skin models. Coletica’s offerings now enhance Engelhard’s existing personal care materials, providing customers with a unique combination of technical expertise in active ingredient technologies, base materials and formulation and evaluation services.

Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss. It also offers drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. The company was founded in October 2015 and is headquartered in Boston, MA.

Koshihua (Nanjing) Biotechnology Co., Ltd., established on 2021-10-11, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Artificial intelligence basic software development;Artificial intelligence application software development;Artificial intelligence theory and algorithm software development;software development;Development of Human Gene Diagnosis and Therapy Technology;Technical extension services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)